Kymera Therapeutics Inc (KYMR)
39.09
+0.59
(+1.53%)
USD |
NASDAQ |
May 09, 14:53
Kymera Therapeutics Price: 39.09 for May 9, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 08, 2024 | 38.02 | 38.91 | 37.65 | 38.50 | 453244.0 |
May 07, 2024 | 38.57 | 39.06 | 38.08 | 38.44 | 331904.0 |
May 06, 2024 | 37.71 | 38.52 | 37.19 | 38.30 | 426797.0 |
May 03, 2024 | 37.35 | 38.21 | 36.06 | 37.40 | 529668.0 |
May 02, 2024 | 36.17 | 36.83 | 35.06 | 36.30 | 502669.0 |
May 01, 2024 | 33.57 | 37.83 | 33.52 | 36.24 | 637582.0 |
Apr 30, 2024 | 34.13 | 34.47 | 33.48 | 33.62 | 481501.0 |
Apr 29, 2024 | 33.75 | 34.71 | 33.66 | 34.66 | 428515.0 |
Apr 26, 2024 | 33.75 | 34.14 | 33.22 | 33.37 | 452364.0 |
Apr 25, 2024 | 34.28 | 34.29 | 32.75 | 33.35 | 786230.0 |
Apr 24, 2024 | 35.66 | 36.47 | 34.67 | 35.21 | 379566.0 |
Apr 23, 2024 | 34.49 | 37.00 | 34.49 | 35.71 | 437029.0 |
Apr 22, 2024 | 34.87 | 35.36 | 33.85 | 34.35 | 417209.0 |
Apr 19, 2024 | 34.98 | 35.53 | 33.35 | 33.97 | 627447.0 |
Apr 18, 2024 | 33.67 | 35.57 | 33.67 | 35.12 | 619729.0 |
Apr 17, 2024 | 34.39 | 34.41 | 33.17 | 33.76 | 433665.0 |
Apr 16, 2024 | 33.78 | 34.76 | 33.58 | 33.93 | 492350.0 |
Apr 15, 2024 | 35.81 | 35.82 | 34.20 | 34.39 | 528869.0 |
Apr 12, 2024 | 36.81 | 36.92 | 34.74 | 35.58 | 598100.0 |
Apr 11, 2024 | 35.61 | 37.32 | 35.43 | 37.21 | 469853.0 |
Apr 10, 2024 | 35.72 | 36.43 | 35.07 | 35.33 | 655356.0 |
Apr 09, 2024 | 36.53 | 37.64 | 35.98 | 37.61 | 494951.0 |
Apr 08, 2024 | 36.70 | 37.18 | 35.88 | 36.37 | 296257.0 |
Apr 05, 2024 | 36.07 | 37.16 | 35.27 | 36.40 | 428984.0 |
Apr 04, 2024 | 37.42 | 38.05 | 36.04 | 36.24 | 471942.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
10.97
Minimum
Oct 27 2023
87.83
Maximum
Dec 28 2020
37.06
Average
33.93
Median
Apr 16 2024
Price Benchmarks
Immunic Inc | 1.28 |
Insmed Inc | 26.38 |
SELLAS Life Sciences Group Inc | 1.29 |
Iovance Biotherapeutics Inc | 13.46 |
Intellia Therapeutics Inc | 24.51 |
Price Related Metrics
PS Ratio | 30.28 |
Price to Book Value | 3.372 |
Earnings Yield | -6.42% |
Market Cap | 2.398B |